Bilge Doğan Taymur
Research Subjects
Research Interests
Bilge Doğan Taymur has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Güldeniz Toklucu
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL SANCAKTEPE ŞEHİR PROF. DR. İLHAN VARANK SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ
4 shared publications - Arzu Bilge Tekin
Department of Obstetrics and Gynecology University of Health Sciences Turkey, Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital Istanbul Turkey
3 shared publications - Niyazi Tug
Department of Obstetrics and Gynecology University of Health Sciences Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital Istanbul Türkiye
3 shared publications - Doğuş Budak
University of Health Sciences Turkey, Şehit Prof. Dr. İlhan Varank Sancaktepe Training and Research Hospital, Clinic of Obstetrics and Gynecology, İstanbul, Turkey
2 shared publications - Murat Yassa
Department of Obstetrics and Gynecology, Acıbadem University Kartal Hospital, Pelvic Floor and Cosmetic Gynecology Association, İstanbul, Türkiye
2 shared publications - Osman Samet Günkaya
University of Health Sciences Turkey, Turkey
2 shared publications
Latest Publications
- Open Access
- 20 July 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (4) , 928-932
Vaccination rate and vaccine hesitancy of pregnant women, comparison of causes with epidemiological factors during SARS-CoV-2 pandemic
Aims: Vaccine hesitancy remains a major challenge in public health, particularly among pregnant women, who represent a high-risk group for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to evaluate SARS-CoV-2 vaccine acceptance and to identify factors related to vaccine hesitancy among pregnant women. This hospital-based, cross-sectional study was conducted among pregnant women attending routine antenatal care clinics at a tertiary healthcare center.Methods: Pregnant women who voluntarily consented to participate were included in the study. Data were collected using a structured questionnaire covering sociodemographic characteristics, obstetric history, presence of chronic disease, history of SARS-CoV-2 infection, vaccination status, and reasons for vaccine hesitancy. During pregnancy, vaccinated and unvaccinated groups were compared using appropriate statistical techniques.Results: A total of 249 pregnant women were included. The overall acceptance rate of the SARS-CoV-2 vaccine was 47.4%. No statistically significant differences were observed between vaccinated and unvaccinated women in terms of age, education level, employment status, income level, obstetric characteristics, presence of chronic disease, or history of SARS-CoV-2 infection (p>0.05). Gestational age was significantly higher among unvaccinated women compared with vaccinated women (p
- 20 July 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (4) , 928-932
Open AccessVaccination rate and vaccine hesitancy of pregnant women, comparison of causes with epidemiological factors during SARS-CoV-2 pandemic
Aims: Vaccine hesitancy remains a major challenge in public health, particularly among pregnant women, who represent a high-risk group for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to evaluate SARS-CoV-2 vaccine acceptance and to identify factors related to vaccine hesitancy among pregnant women. This hospital-based, cross-sectional study was conducted among pregnant women attending routine antenatal care clinics at a tertiary healthcare center.Methods: Pregnant women who voluntarily consented to participate were included in the study. Data were collected using a structured questionnaire covering sociodemographic characteristics, obstetric history, presence of chronic disease, history of SARS-CoV-2 infection, vaccination status, and reasons for vaccine hesitancy. During pregnancy, vaccinated and unvaccinated groups were compared using appropriate statistical techniques.Results: A total of 249 pregnant women were included. The overall acceptance rate of the SARS-CoV-2 vaccine was 47.4%. No statistically significant differences were observed between vaccinated and unvaccinated women in terms of age, education level, employment status, income level, obstetric characteristics, presence of chronic disease, or history of SARS-CoV-2 infection (p>0.05). Gestational age was significantly higher among unvaccinated women compared with vaccinated women (p
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Do serum homocysteine levels affect female sexual function in reproductive-age women: a cross-sectional study
SUMMARY OBJECTIVE: The aim of this study was to investigate the association between serum homocysteine levels and female sexual function in reproductive-age women presenting with sexual dysfunction complaints and to evaluate relationships with vitamin B12 and folic acid levels. METHODS: This cross-sectional study included 114 sexually active women aged 18–45 years presenting with sexual dysfunction complaints. Female sexual function was assessed using the Female Sexual Function Index. Fasting serum homocysteine, vitamin B12, and folic acid levels were measured. Correlation analyses, group comparisons, and multivariable linear regression were performed. A priori sample size calculation indicated that at least 84 participants were required to detect a moderate correlation (ρ=0.30) with 80% power. RESULTS: Female Sexual Function Index scores were available for 111 participants and homocysteine levels for 99 participants. The mean Female Sexual Function Index total score was 24.69±4.34, below the established cut-off for sexual dysfunction. Serum homocysteine levels were not associated with Female Sexual Function Index total or domain scores (ρ=-0.035, p=0.726). No significant differences were observed between homocysteine groups defined by ≤10 and >10 μmol/L or ≤15 and >15 μmol/L. Age showed a moderate negative correlation with the desire domain (ρ=-0.362, p<0.001). In multivariable regression, homocysteine, vitamin B12, and folic acid were not independent predictors of Female Sexual Function Index total score. CONCLUSION: In this symptomatic population, homocysteine levels were not associated with female sexual function. These findings should be interpreted cautiously due to the lack of a control group. Further large-scale, population-based studies are needed.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (6)
Open AccessDo serum homocysteine levels affect female sexual function in reproductive-age women: a cross-sectional study
SUMMARY OBJECTIVE: The aim of this study was to investigate the association between serum homocysteine levels and female sexual function in reproductive-age women presenting with sexual dysfunction complaints and to evaluate relationships with vitamin B12 and folic acid levels. METHODS: This cross-sectional study included 114 sexually active women aged 18–45 years presenting with sexual dysfunction complaints. Female sexual function was assessed using the Female Sexual Function Index. Fasting serum homocysteine, vitamin B12, and folic acid levels were measured. Correlation analyses, group comparisons, and multivariable linear regression were performed. A priori sample size calculation indicated that at least 84 participants were required to detect a moderate correlation (ρ=0.30) with 80% power. RESULTS: Female Sexual Function Index scores were available for 111 participants and homocysteine levels for 99 participants. The mean Female Sexual Function Index total score was 24.69±4.34, below the established cut-off for sexual dysfunction. Serum homocysteine levels were not associated with Female Sexual Function Index total or domain scores (ρ=-0.035, p=0.726). No significant differences were observed between homocysteine groups defined by ≤10 and >10 μmol/L or ≤15 and >15 μmol/L. Age showed a moderate negative correlation with the desire domain (ρ=-0.362, p<0.001). In multivariable regression, homocysteine, vitamin B12, and folic acid were not independent predictors of Female Sexual Function Index total score. CONCLUSION: In this symptomatic population, homocysteine levels were not associated with female sexual function. These findings should be interpreted cautiously due to the lack of a control group. Further large-scale, population-based studies are needed.
- 22 March 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (1) , 1-6
TÜRKİYE’DEKİ SURİYELİ GÖÇMEN GEBE KADINLARIN DOĞUM ÖZELLİKLERİ VE OBSTETRİK SONUÇLARININ TÜRKİYELİ GEBE KADINLARIN SONUÇLARI İLE KARŞILAŞTIRILMASI
Amaç: Dünyada ülkeler arası artan göçler nedeniyle göçmen sağlığı önem kazanmıştır. Göçün sağlık üzerindeki etkisi; başta sosyodemografik ve ekonomik olmak üzere geniş kapsamlı değerlendirilmelidir. Çalışmanın amacı Türkiye'deki Suriyeli mülteci kadınların doğum öncesi bakım, gebelik ve yenidoğan sonuçlarını değerlendirmek ve yerel halkla karşılaştırmaktır. Materyal ve Metod: Eylül 2020-Ekim 2021 tarihleri arasında Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği'ne başvuran 5113 gebe retrospektif olarak tarandı. Gruplar demografik veriler, obstetrik özellikler ve gebelik sonuçları açısından karşılaştırıldı. Bulgular: Türkiye vatandaşı olan olguların yaşları, Suriyeli olguların yaşlarından istatistiksel olarak anlamlı düzeyde daha yüksek saptanmıştır (p=0,001; p
- 22 March 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (1) , 1-6
TÜRKİYE’DEKİ SURİYELİ GÖÇMEN GEBE KADINLARIN DOĞUM ÖZELLİKLERİ VE OBSTETRİK SONUÇLARININ TÜRKİYELİ GEBE KADINLARIN SONUÇLARI İLE KARŞILAŞTIRILMASI
Amaç: Dünyada ülkeler arası artan göçler nedeniyle göçmen sağlığı önem kazanmıştır. Göçün sağlık üzerindeki etkisi; başta sosyodemografik ve ekonomik olmak üzere geniş kapsamlı değerlendirilmelidir. Çalışmanın amacı Türkiye'deki Suriyeli mülteci kadınların doğum öncesi bakım, gebelik ve yenidoğan sonuçlarını değerlendirmek ve yerel halkla karşılaştırmaktır. Materyal ve Metod: Eylül 2020-Ekim 2021 tarihleri arasında Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği'ne başvuran 5113 gebe retrospektif olarak tarandı. Gruplar demografik veriler, obstetrik özellikler ve gebelik sonuçları açısından karşılaştırıldı. Bulgular: Türkiye vatandaşı olan olguların yaşları, Suriyeli olguların yaşlarından istatistiksel olarak anlamlı düzeyde daha yüksek saptanmıştır (p=0,001; p
- Open Access
- 3 December 2024
- Published by Iberoamerican Journal of Medicine in Iberoamerican Journal of Medicine
- Vol. 7 (1) , 4-10
Efficacy in prenatal vitamin B12 supplementation preventing vitamin B12 deficiency in exclusively breastfed infants
Introduction: Vitamin B12 is essential for erythropoiesis, cell proliferation, nucleoprotein and myelin synthesis, and normal growth and development of cognitive functions. Material and methods: A retrospective cohort follow-up study is planned to determine vitamin B12 levels and to reveal the symptoms that occur in deficiency. A complete blood count is conducted as part of the standard protocol for pregnant women (third trimester) of pregnancy. At six months of age, the infant's serum vitamin B12 level, iron concentration, ferritin level, and complete blood count are assessed. 70 mother-baby pairs were followed up over the period from 01/01/2021 to 01/01/2022. The infant cohort included 51.4% boys (n=36) and 48.6% girls (n=34). Results: It was observed that 58.5% (n=41) of the mothers used multivitamin supplements, and 80% of them used iron medication. When the babies of mothers who took a multivitamin containing B12 were compared with the babies of other mothers, it was observed that there was a statistical significance in the B12 levels of the babies (p=0.012). Discussion: The effects of B12 supplementation given to mothers on the intelligence development of children were investigated. It was hypothesised that the recommendation to provide routine vitamin B12 supplementation to mothers could be incorporated into the existing guidelines. The concept was initially proposed during the course of the study. It is our view that the administration of vitamin B12 supplements to mothers has a beneficial effect on the vitamin B12 levels of their babies, and that vitamin B12 supplementation should be provided to mothers. Studies conducted in our country and in the world show that keeping the vitamin B12 level high during pregnancy and lactation is important for the health of the mother and baby. It is therefore recommended that pregnant women receive vitamin B12 supplementation, with continued supplementation for the first six months postpartum.
- 3 December 2024
- Published by Iberoamerican Journal of Medicine in Iberoamerican Journal of Medicine
- Vol. 7 (1) , 4-10
Open AccessEfficacy in prenatal vitamin B12 supplementation preventing vitamin B12 deficiency in exclusively breastfed infants
Introduction: Vitamin B12 is essential for erythropoiesis, cell proliferation, nucleoprotein and myelin synthesis, and normal growth and development of cognitive functions. Material and methods: A retrospective cohort follow-up study is planned to determine vitamin B12 levels and to reveal the symptoms that occur in deficiency. A complete blood count is conducted as part of the standard protocol for pregnant women (third trimester) of pregnancy. At six months of age, the infant's serum vitamin B12 level, iron concentration, ferritin level, and complete blood count are assessed. 70 mother-baby pairs were followed up over the period from 01/01/2021 to 01/01/2022. The infant cohort included 51.4% boys (n=36) and 48.6% girls (n=34). Results: It was observed that 58.5% (n=41) of the mothers used multivitamin supplements, and 80% of them used iron medication. When the babies of mothers who took a multivitamin containing B12 were compared with the babies of other mothers, it was observed that there was a statistical significance in the B12 levels of the babies (p=0.012). Discussion: The effects of B12 supplementation given to mothers on the intelligence development of children were investigated. It was hypothesised that the recommendation to provide routine vitamin B12 supplementation to mothers could be incorporated into the existing guidelines. The concept was initially proposed during the course of the study. It is our view that the administration of vitamin B12 supplements to mothers has a beneficial effect on the vitamin B12 levels of their babies, and that vitamin B12 supplementation should be provided to mothers. Studies conducted in our country and in the world show that keeping the vitamin B12 level high during pregnancy and lactation is important for the health of the mother and baby. It is therefore recommended that pregnant women receive vitamin B12 supplementation, with continued supplementation for the first six months postpartum.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20230918
Is polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
OBJECTIVE: The objective of this study was to learn more about the prevalence and pathophysiology of depression and anxiety that may be caused by polycystic ovary syndrome and to make plans for taking necessary precautions for this vulnerable group.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 70 (3) , e20230918
Open AccessIs polycystic ovary syndrome a risk factor for depression and anxiety?: a cross-sectional study
OBJECTIVE: The objective of this study was to learn more about the prevalence and pathophysiology of depression and anxiety that may be caused by polycystic ovary syndrome and to make plans for taking necessary precautions for this vulnerable group.
- 16 September 2022
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 10 (3) , 270-275
Trimester Specific Reference Ranges for Thyroid Hormones in Pregnancy with Multiples of Median Values
- 16 September 2022
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 10 (3) , 270-275
Trimester Specific Reference Ranges for Thyroid Hormones in Pregnancy with Multiples of Median Values
- Open Access
- 27 June 2022
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 19 (2) , 88-97
COVID-19 related maternal mortality cases in associated with Delta and Omicron waves and the role of lung ultrasound
To present coronavirus disease-2019 (COVID-19) related maternal mortality in relation to Delta and Omicron waves and to investigate the role of lung ultrasound (LUS) in estimating mortality. This retrospective cohort study was conducted in the obstetrics and gynecology clinic of a tertiary pandemic hospital between March 2020 and January 2022. The hospitalized pregnant women with COVID-19 diagnosis and maternal deaths were studied in relation with Delta and Omicron waves. The relationship between LUS scores of hospitalized patients and maternal mortality was explored. Thousand and sixty-five pregnant women were hospitalized because of COVID-19 infection. Fifty-one (4.79%) of these patients had critical sickness, 96 (9.01%) of them had severe illness, 62 (5.82%) of them were admitted to the intensive care unit and 28 (2.63%) of all hospitalized pregnant women had died. Of the 1.065 patients, 783 (73.5%) were hospitalized before the Delta wave and the maternal mortality rate was 1.28% (10/783), 243 (22.8%) were hospitalized during the Delta wave and the maternal mortality rate was 7% (17/243) [relative risk (RR)=5.478, 95% confidence interval (CI) (2.54-11.8), z=4.342, p<0.001]. During the Omicron wave 39 (3.66%) patients were hospitalized and the maternal mortality rate was 2.56% (1/39). Maternal mortality rates, according to LUS scores, were 0.37% (1/273) for LUS 0, 0.72% (2/277) for LUS 1, 2.58% (10/387) for LUS 2 and 11.72% (15/128) for LUS 3 respectively (LUS 3 vs. others; maternal mortality: RR=8.447, 95% CI (4.11-17.34), z=5.814, p<0.0001). There were no vaccinated patients in the study cohort. The maternal mortality rate was relatively high, particularly during the Delta wave at our referral center. The Delta wave, delayed vaccination and vaccine hesitancy of pregnant women might have important roles in maternal mortality. Higher LUS scores should warn clinicians of an increased risk of maternal death.
- 27 June 2022
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 19 (2) , 88-97
Open AccessCOVID-19 related maternal mortality cases in associated with Delta and Omicron waves and the role of lung ultrasound
To present coronavirus disease-2019 (COVID-19) related maternal mortality in relation to Delta and Omicron waves and to investigate the role of lung ultrasound (LUS) in estimating mortality. This retrospective cohort study was conducted in the obstetrics and gynecology clinic of a tertiary pandemic hospital between March 2020 and January 2022. The hospitalized pregnant women with COVID-19 diagnosis and maternal deaths were studied in relation with Delta and Omicron waves. The relationship between LUS scores of hospitalized patients and maternal mortality was explored. Thousand and sixty-five pregnant women were hospitalized because of COVID-19 infection. Fifty-one (4.79%) of these patients had critical sickness, 96 (9.01%) of them had severe illness, 62 (5.82%) of them were admitted to the intensive care unit and 28 (2.63%) of all hospitalized pregnant women had died. Of the 1.065 patients, 783 (73.5%) were hospitalized before the Delta wave and the maternal mortality rate was 1.28% (10/783), 243 (22.8%) were hospitalized during the Delta wave and the maternal mortality rate was 7% (17/243) [relative risk (RR)=5.478, 95% confidence interval (CI) (2.54-11.8), z=4.342, p<0.001]. During the Omicron wave 39 (3.66%) patients were hospitalized and the maternal mortality rate was 2.56% (1/39). Maternal mortality rates, according to LUS scores, were 0.37% (1/273) for LUS 0, 0.72% (2/277) for LUS 1, 2.58% (10/387) for LUS 2 and 11.72% (15/128) for LUS 3 respectively (LUS 3 vs. others; maternal mortality: RR=8.447, 95% CI (4.11-17.34), z=5.814, p<0.0001). There were no vaccinated patients in the study cohort. The maternal mortality rate was relatively high, particularly during the Delta wave at our referral center. The Delta wave, delayed vaccination and vaccine hesitancy of pregnant women might have important roles in maternal mortality. Higher LUS scores should warn clinicians of an increased risk of maternal death.